CTA organises an online event to identify risks and create solutions to accelerate the transition to bio-based products

Submitted by David Paez on 25 March 2021

Image
bioswitch3
  • This meeting is part of the European BIOSWITCH project that aims to bring Europe to the forefront of the bioeconomy by encouraging and supporting brand owners to adopt bio-based approaches.

CTA gathered more than 30 attendees in an online event to validate the results of a study on the main risks of adopting bio-based products, and create a set of solutions. The event had a co-creation space in which attendees examined and formulated efficient solutions to mitigate these risks.

The study has been carried out at the European level within the framework of the BIOSWITCH project, in which CTA participates as a partner. This project aims to bring Europe to the forefront of the bioeconomy, encouraging and supporting brand owners to adopt bio-based approaches.

According to the results of the BIOSWITCH study, the main barriers to incorporate bio-based products are high price (100%), uncertainty around functional performance (66%) and insufficient demand from customers (66%). However, Spanish brands are optimistic about the growth in demand for bio-based products, as 66% of them forecast strong to moderate growth in the coming years.

BIOSWITCH is an initiative funded by the Bio-Based Industries Joint Undertaking (BBI JU) under the European Union's Horizon 2020 research and innovation programme.

The results of the analysis at European level and the recording of the event will be published in the coming weeks on the project website: bioswitch.eu.

Cluster organisation
CTA Biotech
Share this Article